134 related articles for article (PubMed ID: 37792304)
21. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Miyauchi J; Ohyashiki K; Inatomi Y; Toyama K
Blood; 1997 Jul; 90(2):803-13. PubMed ID: 9226181
[TBL] [Abstract][Full Text] [Related]
22. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
[TBL] [Abstract][Full Text] [Related]
23. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
Ghavamzadeh A; Jalili M; Rostami S; Yaghmaie M; Aliabadi LS; Mousavi SA; Vaezi M; Fumani HK; Jahani M; Alimoghaddam K
Leuk Res; 2018 Mar; 66():85-88. PubMed ID: 29407588
[TBL] [Abstract][Full Text] [Related]
24. Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.
Chamoun K; Kantarjian HM; Wang X; Naqvi K; Aung F; Garcia-Manero G; Borthakur G; Jabbour E; Kadia T; Daver N; DiNardo CD; Jain N; Konopleva M; Cortes J; Ravandi F; Yilmaz M
Cancer; 2019 Sep; 125(18):3219-3224. PubMed ID: 31150121
[TBL] [Abstract][Full Text] [Related]
25. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
26. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
Gillis JC; Goa KL
Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
[TBL] [Abstract][Full Text] [Related]
27. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
[TBL] [Abstract][Full Text] [Related]
28. High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Leuk Res; 2013 Jan; 37(1):37-42. PubMed ID: 23017225
[TBL] [Abstract][Full Text] [Related]
29. All-trans-retinoic acid induced enrichment of functionally normal neutrophils in vivo in a patient with acute promyelocytic leukemia.
Itoh Y; Ohyashiki K; Ohtaka M; Furuya T; Toyama K; Kuratsuji T; Ohno R
Leukemia; 1992 Aug; 6(8):806-8. PubMed ID: 1640732
[TBL] [Abstract][Full Text] [Related]
30. Acute promyelocytic leukemia with myelofibrosis: A case report and literature review.
Xiao M; Qin L; Niu X; Zhou P; Niu J; Wei S; Li D; Dou L; Zhang W; Zhang L; Sun K; Bai Y
Medicine (Baltimore); 2021 Apr; 100(13):e24567. PubMed ID: 33787572
[TBL] [Abstract][Full Text] [Related]
31. [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia].
Degos L
Presse Med; 1990 Oct; 19(32):1483-4. PubMed ID: 2146649
[No Abstract] [Full Text] [Related]
32. Acute colonic pseudo-obstruction (Ogilvie's syndrome) during induction treatment with chemotherapy and all-trans-retinoic acid for acute promyelocytic leukemia.
Delmer A; Cymbalista F; Bauduer F; Martin A; Rio B; Fenaux P; Marie JP; Zittoun R
Am J Hematol; 1995 May; 49(1):97-8. PubMed ID: 7741149
[No Abstract] [Full Text] [Related]
33. Acute Promyelocytic Leukemia and HIV: Case Reports and a Review of the Literature.
Kunitomi A; Hasegawa Y; Lmamura J; Yokomaku Y; Tokunaga T; Miyata Y; Iida H; Nagai H
Intern Med; 2019 Aug; 58(16):2387-2391. PubMed ID: 31118366
[TBL] [Abstract][Full Text] [Related]
34. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
Fujita H; Ishikawa Y; Yokoyama Y
Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
[No Abstract] [Full Text] [Related]
35. [The special position of promyelocytic leukemia: complete remission after treatment with vitamin A derivatives].
Löffler H
Dtsch Med Wochenschr; 1991 Apr; 116(14):553-4. PubMed ID: 2013258
[No Abstract] [Full Text] [Related]
36. Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
Hernández P; Martinez G; Losada R; Machín S; Cayado N; Gramatges A
Haematologica; 2002 Mar; 87(3):ELT14. PubMed ID: 11869960
[No Abstract] [Full Text] [Related]
37. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
[TBL] [Abstract][Full Text] [Related]
38. A Novel Inclusion Body in Acute Promyelocytic Leukemia.
Dong SX; Liu J; Ru YX
Turk J Haematol; 2023 Feb; 40(1):68-69. PubMed ID: 36582734
[No Abstract] [Full Text] [Related]
39. [Treatment of acute promyelocytic leukemia].
Asou N
Nihon Rinsho; 2007 Jan; 65 Suppl 1():483-7. PubMed ID: 17474452
[No Abstract] [Full Text] [Related]
40. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
